Patient Consent Management Solutions Startup HealthEx Raises $14M
A California-based startup called HealthEx, which is building a consumer preference and consent platform for healthcare, has raised $14 million in seed and Series A funding led by General Catalyst, with participation by Electric Capital.
The company said it will use the funding to scale development to simplify integrating the patient voice across all healthcare activities.
HealthEx called its solution one of the first AI platforms that enables healthcare organizations to easily create, collect, and enforce patient consent and preferences, and allow health systems to fulfill their roles as trusted stewards of patient data.
“As health systems embark on a new era of AI-driven care, one area ripe for disruption is analog consent and data access processes that leave consumers unsure of their choices and health systems open to security and compliance risks,” said Stephen Klasko, M.D., special advisor with General Catalyst and former CEO of Thomas Jefferson Health in Philadelphia, in a statement. “By enabling ethical access to proprietary health data, HealthEx can help organizations maintain patient trust and transform their operations to generate greater value through their health data.”
Part of the challenge the company is addressing involves data use and licensing. HealthEx says patients and healthcare organizations need a more streamlined, transparent approach to ensure trust and compliance in today’s data-driven landscape.
HealthEx said its platform involves AI agents helping clinical staff generate consents for different use cases during the care journey to reduce manual effort. Data and compliance administrators can programmatically enforce granular consents and leverage AI-assisted risk assessments of existing consents, giving them confidence that preferences and all sources of data policy are followed through via HealthEx’s APIs, gateways, and secure data vaults.
“As healthcare organizations face new complexities in data use and licensing, it’s clear that both patients and providers need a more streamlined, transparent solution to ensure trust and compliance in today’s data-driven landscape,” said Priyanka Agarwal, M.D., M.B.A., co-founder and CEO of HealthEx, in a statement. She was previously at UCSF and MyoKardia, acquired by Bristol Myers Squibb, “We allow healthcare organizations to manage this data effectively while giving patients more control over their healthcare decisions and creating a more transparent process. Our vision is to manage patient preferences and consent for individuals across every healthcare touchpoint with a unified experience for preferences, consent, and data access management.”
Also a co-founder is Anand Raghavan, who was previously part of the founding team and vice president of engineering at BlueJeans, acquired by Verizon.
HealthEx said it makes patient and health system data preferences and policies available to ecosystem collaborators in formats compatible with emerging HL7 Consent FHIR standards.
HealthEx was hatched by General Catalyst and is deeply integrated with the VC firm's Health Assurance network.
